AI - Publications - Faculty & Research - Harvard Business School

Instawork Co-Founder and CEO Sumir Meghani on the company's shift work platform. The intermediary touts better, data-driven matches and a more efficient market. How do the algorithmic decisions boost outcomes for workers and businesses? View Details

27 Feb 2025
News

Harnessing AI and Experimentation in Startups feat. Jeffrey J. Bussgang

30 May 2023
News

What makes Nvidia's chips so special during this AI boom?

12 Apr 2021
News

BMW’s Virtual Factory Uses AI to Hone the Assembly Line

17 Nov 2023
Video

Entrepreneurial Insights: Brandon Tseng, Co-founder and President of Shield AI

23 Sep 2020
News

The Next Big Breakthrough in AI Will Be Around Language

Keywords: Artificial intelligence

Forthcoming
Article

An AI Method to Score Celebrity Visual Potential from Human Faces

By: Flora Feng, Shunyuan Zhang, Xiao Liu, Kannan Srinivasan and Cait Lamberton

It has long been a mantra of marketing practice that, particularly in low-involvement situations, spokespeople should be physically attractive. This paper suggests there is a higher probability of gaining fame and influence (i.e., celebrity potential) than is captured... View Details

Keywords: Personal Characteristics; AI and Machine Learning; Forecasting and Prediction; Marketing

07 Aug 2024
Podcast

EY’s Trent Henry on how AI can extend white-collar careers

The consulting giant’s global talent lead explains how the firm is bringing mass customization and accountability to skills building and integrating human and ‘synthetic’ skills. Also, the bottom-line benefit of promoting employee health and wellness. View Details

29 Sep 2023
News

Eliminating Algorithmic Bias Is Just the Beginning of Equitable AI

08 Oct 2020
News

Sales Calls Have Gone Virtual, and AI Is Listening In

12 Apr 2023
News

Generative AI Will Change Your Business. Here’s How to Adapt.

June 2023
Case

Verve Therapeutics: Taking DNA Editing to Heart

By: Shikhar Ghosh and Shweta Bagai

Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details